Comparative Pharmacology
Head-to-head clinical analysis: TELDRIN versus ZYRTEC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: TELDRIN versus ZYRTEC.
TELDRIN vs ZYRTEC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
TELDRIN contains loratadine and pseudoephedrine. Loratadine is a long-acting tricyclic antihistamine with selective peripheral H1-receptor antagonism. Pseudoephedrine is a sympathomimetic amine that acts as a decongestant by stimulating alpha-adrenergic receptors in the respiratory tract mucosa, causing vasoconstriction.
Selective histamine H1-receptor antagonist; inhibits histamine release from mast cells and basophils.
1-2 mg orally twice daily; maximum 4 mg/day.
5-10 mg orally once daily; maximum 10 mg/day.
None Documented
None Documented
Terminal half-life: 9-12 hours (range 8-14) in healthy adults; prolonged in renal impairment.
Terminal elimination half-life is approximately 8-11 hours in healthy adults, prolonged in renal impairment (e.g., up to 20 hours in moderate renal failure).
Renal: 55-60% unchanged; fecal: 35-40%; minor biliary elimination.
Cetirizine is primarily excreted unchanged in urine (approximately 70% renal elimination) and feces (about 10%).
Category C
Category C
Antihistamine
Antihistamine